N-aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity
CA 2468967 A1 · Owner: Palani, Anandan · Inventors: Mc Briar, Mark D.; Su, Jing; Clader, John W.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention discloses compounds of the formula I which are novel , antagonists for melanin-concentrating hormone (MCH) as well as methods for , preparing such compounds. In another embodiment the invention discloses , pharmaceutical compositions comprising such MCH antagonists as well as methods of using them to treat obesity, metabolic disorders eating disorders such as , hyperphagia and diabetes.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 3, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 3, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 3, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.